biopharma - International Biopharmaceutical Industry

news

Biopharma Takes on Deadly Brain Cancer After Decades of Failure

Emboldened by technological advances and a deeper knowledge of glioblastoma, Merck, Kazia Therapeutics, CorriXR Therapeutics and others are targeting the often-fatal...

2 December 2024 news biopharma | biopharmaceutical

Continue Reading →

news

Abingworth ‘Will Launch $1.5bn Fund for Co-developed Drugs’

Venture capital group Abingworth is reportedly trying to raise up to $1.5 billion in investment funding to support biopharma companies' clinical development programm...

2 December 2024 news Abingworth | biopharma

Continue Reading →

news

Sanofi Opens $590M Modular Vaccine, Biologics Plant in Singapore

Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be reconfigured within days during a pan...

2 December 2024 news biologics | biopharma

Continue Reading →

news

FDA Oncology Advisory Committee to Weigh Exelixis’ Cabometyx in Neuroendocrine Tumours

The advisory committee will meet to discuss Cabometyx's phase 3 CABINET study in March 2025. Before Exelexis’ Cabometyx can pass muster with the FDA in its hopefu...

2 December 2024 news biopharma | cancer

Continue Reading →

Volume 4 Issue 4

How Involved Should Biopharma CEOs Be In Outsourcing Activities?

When outsourcing drug development and manufacturing, how involved should the CEOs of emerging biopharma be in the requisite day-to-day activities and processes? Louis...

9 December 2021 Volume 4 Issue 4 Aristea Therapeutics | biopharma

Continue Reading →

news

Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelous™) in Central and Eastern Europe Singapore

Prestige BioPharma and Alvogen today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercia...

29 June 2018 news alvogen | announce

Continue Reading →

news

Alpha Biopharma announces series A financing

AZD3759, AlphaBio's lead product, is a next-generation small molecule tyrosine kinase inhibitor (TKI). It is specifically designed to treat epidermal growth factor r...

22 June 2018 news Alpha | Announces

Continue Reading →

news

Wize Pharma signs distribution agreement in China for LO2A

HPGC is a division of Harbin Pharmaceutical Group Co. Ltd., one of China's largest healthcare companies with 20,000 employees and assets worth $2.9 billion. Wize P...

8 June 2018 news biopharma | Harbin

Continue Reading →

news

Johnson & Johnson has the most bucks for biopharma M&A, Astellas the easiest target: analyst

The $62 billion Takeda-Shire deal surprised everyone—and worries some—as Takeda is borrowing an enormous $31 billion to help pay for the purchase. Does it refresh the...

1 June 2018 news Astellas | biopharma

Continue Reading →

A-D

Biopharma Group

The Biopharma Group comprises of Biopharma Process Systems (BPS), Biopharma Technologies Ltd (BTL), Biopharma Technology LLC (USA) and Biopharma Technologies France (...

31 May 2018 A-D biopharma | Biotech

Continue Reading →